LFSC:NSD-F/m Emerald Life Sciences Innovation ETF (USD)

ETF | Others |

Last Closing

USD 23.093

Change

-0.30 (-1.27)%

Market Cap

USD 0.05B

Volume

1.20K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+1.74 (+3.01%)

USD 45.40B
QQQM Invesco NASDAQ 100 ETF

+3.20 (+1.53%)

USD 39.18B
JEPQ JPMorgan Nasdaq Equity Premium..

+0.12 (+0.23%)

USD 22.49B
ACWI iShares MSCI ACWI ETF

+0.65 (+0.53%)

USD 19.99B
CGABL The Carlyle Group Inc. 4.625% ..

-0.03 (-0.18%)

USD 16.14B
SNDK Sandisk Corp

+0.73 (+1.77%)

USD 5.99B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 5.43B
TSLL Direxion Shares ETF Trust - Di..

+1.24 (+9.63%)

USD 4.44B
NVDL GraniteShares 1.5x Long NVDA D..

+4.91 (+11.15%)

USD 3.52B
USCL iShares Climate Conscious & Tr..

+0.34 (+0.49%)

USD 2.21B

ETFs Containing LFSC

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.27% 38% F 56% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.27% 37% F 55% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.05B 57% F 29% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike